Argyle Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
Argyle Capital Partners's TMO Position: Q3 2026 in Review
Argyle Capital Partners reduced its Thermo Fisher Scientific (TMO) stake by 18% in Q3 2026, selling an estimated $75.4K and leaving 593 shares worth $400K. The position accounts for 0.25% of the portfolio, ranked #104.
Argyle Capital Partners first reported a position in TMO in Q2 2025 and has held it in 6 quarters since. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Argyle Capital Partners held 593 shares of Thermo Fisher Scientific worth $400K as of Q3 2026.
- Argyle Capital Partners sold 127 Thermo Fisher Scientific shares in Q3 2026, an estimated $75.4K.
- Thermo Fisher Scientific made up 0.25% of Argyle Capital Partners's portfolio in Q3 2026, its #104 holding.
- Argyle Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 6 quarters since.
- 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Argyle Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.